142 related articles for article (PubMed ID: 36476790)
1. [Hemophagocytic lymphohistiocytosis following mRNA-1273 COVID-19 vaccination].
Matsui S; Tokunaga M; Yoshikawa S; Hasegawa C; Kondo A; Nishiura N; Inoue S; Tominaga N; Maeda T
Rinsho Ketsueki; 2022; 63(11):1513-1519. PubMed ID: 36476790
[TBL] [Abstract][Full Text] [Related]
2. Hemophagocytic lymphohistiocytosis after COVID-19 vaccination.
Tang LV; Hu Y
J Hematol Oncol; 2021 Jun; 14(1):87. PubMed ID: 34088334
[TBL] [Abstract][Full Text] [Related]
3. Hypocomplementemic urticarial vasculitis case with hemophagocytic lymphohistiocytosis following SARS-CoV-2 mRNA vaccination.
Iwamura N; Eguchi K; Koga T; Tsutsumi K; Araki T; Aramaki T; Takatani A; Terada K; Ueki Y
Immunol Med; 2023 Jun; 46(2):97-107. PubMed ID: 36950829
[TBL] [Abstract][Full Text] [Related]
4. [Epstein-Barr virus-associated lymphoproliferative disorders after BNT162b2 mRNA COVID-19 vaccination].
Tanaka A; Kawaguchi T; Imadome KI; Hara S
Rinsho Ketsueki; 2023; 64(4):277-282. PubMed ID: 37121772
[TBL] [Abstract][Full Text] [Related]
5. Pediatric hemophagocytic lymphohistiocytosis after concomitant administration of SARS-CoV-2 vaccine and influenza vaccine.
Kaizuka A; Tokuda Y; Morooka S; Gocho Y; Funaki T; Uchiyama T; Hirata Y; Yasumi T; Maekawa T; Kubota M; Ishiguro A
J Infect Chemother; 2024 Jan; 30(1):67-70. PubMed ID: 37657516
[TBL] [Abstract][Full Text] [Related]
6. A case of hemophagocytic lymphohistiocytosis after BNT162b2 COVID-19 (Comirnaty®) vaccination.
Shimada Y; Nagaba Y; Okawa H; Ehara K; Okada S; Yokomori H
Medicine (Baltimore); 2022 Oct; 101(43):e31304. PubMed ID: 36316859
[TBL] [Abstract][Full Text] [Related]
7. Patients presenting high fever with lymphadenopathy after COVID-19 vaccination were diagnosed with hemophagocytic lymphohistiocytosis.
Baek DW; Hwang S; Kim J; Lee JM; Cho HJ; Moon JH; Hwang N; Jeong JY; Lee SW; Sohn SK
Infect Dis (Lond); 2022 Apr; 54(4):303-307. PubMed ID: 34854350
[TBL] [Abstract][Full Text] [Related]
8. Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination.
Hieber ML; Sprute R; Eichenauer DA; Hallek M; Jachimowicz RD
Infection; 2022 Oct; 50(5):1399-1404. PubMed ID: 35218512
[TBL] [Abstract][Full Text] [Related]
9. A Case of Hemophagocytic Lymphohistiocytosis following Second Dose of COVID-19 Vaccination.
Park HW; Min GJ; Kim TY; Cho SG
Acta Haematol; 2023; 146(1):65-71. PubMed ID: 36096118
[TBL] [Abstract][Full Text] [Related]
10. Hemophagocytic Lymphohistiocytosis as the Presenting Manifestation of Relapsed Classic Hodgkin's Lymphoma in the Presence of Concurrent Human Immunodeficiency Virus, Genital Herpes, Epstein-Barr Virus and Mycobacterium Avium Complex Infection.
Siddiqui RS; Agladze M; Bashir T
Cureus; 2020 Nov; 12(11):e11563. PubMed ID: 33364090
[TBL] [Abstract][Full Text] [Related]
11. Lessons of the month 3: Haemophagocytic lymphohistiocytosis following COVID-19 vaccination (ChAdOx1 nCoV-19).
Cory P; Lawrence H; Abdulrahim H; Mahmood-Rao H; Hussein A; Gane J
Clin Med (Lond); 2021 Nov; 21(6):e677-e679. PubMed ID: 34862234
[TBL] [Abstract][Full Text] [Related]
12. Probable secondary hemophagocytic lymphohistiocytosis manifesting as central nervous system lesions after COVID-19 vaccination: a case report.
Kim JH; Chung JY; Bong JB
Front Neurol; 2024; 15():1363072. PubMed ID: 38529033
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Virus Versus Novel Coronavirus-Induced Hemophagocytic Lymphohistocytosis: The Uncharted Waters.
Amir R; Kichloo A; Singh J; Bhanot R; Aljadah M; Kumar A; Albosta MS; Solanki S
J Investig Med High Impact Case Rep; 2020; 8():2324709620950107. PubMed ID: 32787459
[TBL] [Abstract][Full Text] [Related]
14. Polymerase chain reaction amplification of archival material for Epstein-Barr virus, cytomegalovirus, human herpesvirus 6, and parvovirus B19 in children with bone marrow hemophagocytosis.
Hoang MP; Dawson DB; Rogers ZR; Scheuermann RH; Rogers BB
Hum Pathol; 1998 Oct; 29(10):1074-7. PubMed ID: 9781644
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr Virus-Positive Hemophagocytic Lymphohistiocytosis Following COVID-19 Vaccination in a Pediatric Patient.
Arand A; Overholt K; Jacob SA; Belsky JA
Pediatr Blood Cancer; 2023 May; 70(5):e30189. PubMed ID: 36632038
[No Abstract] [Full Text] [Related]
16. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.
Hu S; Bansal P; Lynch D; Rojas Hernandez CM; Dayao Z
J Med Case Rep; 2016 Dec; 10(1):365. PubMed ID: 27998299
[TBL] [Abstract][Full Text] [Related]
17. Fatal hemophagocytic lymphohistiocytosis with intravascular large B-cell lymphoma following coronavirus disease 2019 vaccination in a patient with systemic lupus erythematosus: an intertwined case.
Ueda Y; Sakai T; Yamada K; Arita K; Ishige Y; Hoshi D; Yanagisawa H; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Yamada S; Yachie A; Masaki Y
Immunol Med; 2024 Apr; ():1-8. PubMed ID: 38619098
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.
Kogawa K; Sato H; Asano T; Ohga S; Kudo K; Morimoto A; Ohta S; Wakiguchi H; Kanegane H; Oda M; Ishii E
Pediatr Blood Cancer; 2014 Jul; 61(7):1257-62. PubMed ID: 24535916
[TBL] [Abstract][Full Text] [Related]
19. A Case of Severe Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis Successfully Treated With High Dose Steroids and Ganciclovir.
Budhathoki P; Qureshi ZA; Shah A; Khanal S; Ghazanfar H; Hanif A
Cureus; 2022 Jun; 14(6):e25952. PubMed ID: 35855250
[TBL] [Abstract][Full Text] [Related]
20. Acute fibrinous and organizing pneumonia complicated with hemophagocytic lymphohistiocytosis caused by chronic active Epstein-Barr virus infection: a case report.
Wu X; Wang K; Gao Y; Cai Y; Wang W; Zhong D; Zhan Q
BMC Infect Dis; 2021 Dec; 21(1):1207. PubMed ID: 34863102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]